Literature DB >> 6165764

Monoclonal antibodies against a specific surface determinant on malarial (Plasmodium knowlesi) merozoites block erythrocyte invasion.

N Epstein, L H Miller, D C Kaushel, I J Udeinya, J Rener, R J Howard, R Asofsky, M Aikawa, R L Hess.   

Abstract

Twelve hybridoma cell lines secreting monoclonal antibodies against Plasmodium knowlesi merozoites have been produced. Antibodies from 3 of the 12 lines agglutinated merozoites. The 2 monoclonal antibodies (13C11 and 16F8) that markedly agglutinated merozoites blocked merozoite invasion of erythrocytes. Of these 2 lines, the one that induced the most agglutination also blocked invasion most effectively. The third monoclonal antibody (53B3) caused minimal agglutination of merozoites and did not block invasion, nor did the other 9 nonagglutinating antibodies. The 2 blocking monoclonal antibodies bound to antigens around the entire surface of merozoites, as demonstrated by immunoelectron microscopy, and precipitated a single biosynthetically labeled protein of apparent m.w. of 250,000. None of the nonagglutinating lines precipitated this protein. Monoclonal antibodies 13C11 and 16F8 reacted with a common antigenic determinant on a Malaysian and a Philippine strain of P. knowlesi in that they blocked invasion and precipitated a 250,000 m.w. protein from both. Sera from immune monkeys also precipitated this 250,000 m.w. protein.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6165764

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors.

Authors:  P Vukovic; P M Hogarth; N Barnes; D C Kaslow; M F Good
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Characterization of antigens of the nematode Nippostrongylus brasiliensis by monoclonal antibodies.

Authors:  A Bohn; W König
Journal:  Z Parasitenkd       Date:  1985

3.  Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene.

Authors:  J A Lyon; R H Geller; J D Haynes; J D Chulay; J L Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

4.  The 3' portion of the gene for a Plasmodium yoelii merozoite surface antigen encodes the epitope recognized by a protective monoclonal antibody.

Authors:  J M Burns; T M Daly; A B Vaidya; C A Long
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

5.  The dichotomy (generation of MAbs with functional heterogeneity) in antimalarial immune response in vaccinated/protected mice: a new concept in our understanding of the protective immune mechanisms in malaria.

Authors:  Prati Pal Singh; Bhanu Prakash
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

Review 6.  Comparative biology of intracellular parasitism.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1985-09

7.  Identification and characterization of a major surface antigen of Giardia lamblia.

Authors:  D A Einfeld; H H Stibbs
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Studies of murine malaria antigens using monoclonal antibodies. Production, selection, and characterization of antibodies.

Authors:  G Holmquist; P Borwell; A R Cattan; H Wigzell
Journal:  Z Parasitenkd       Date:  1986

9.  Generalized immunological recognition of the major merozoite surface antigen (gp195) of Plasmodium falciparum.

Authors:  S P Chang; G S Hui; A Kato; W A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

10.  Structure and development of the surface coat of erythrocytic merozoites of Plasmodium knowlesi.

Authors:  L H Bannister; G H Mitchell; G A Butcher; E D Dennis; S Cohen
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.